Biogen, Inc. (NQ: BIIB )
273.84 USD -2.00 (-0.73%) Official Closing Price Updated: 7:39 PM EST, Jan 19, 2021 Add to My Watchlist
Stories about Biogen, Inc.
Why Biogen Shares Rose 2.59% in March
April 02, 2020
Even during a brutal first quarter for the stock market, there were some winners as COVID-19 quickly changed the way people live and work in the U.S.
IBB, VRTX, BIIB, ILMN: ETF Outflow Alert
March 31, 2020
Symbols mentioned in this story: IBB, VRTX, BIIB, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
From ETF Channel
4 Reasons Drug Stocks Are a Buy Right Now
March 30, 2020
Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
The U.S. Food & Drug Administration has authorised the start of a mid-stage trial by U.S.-Israeli NeuroRx and Relief Therapeutics for the use of Aviptadil to treat Acute Respiratory Distress in...
First Week of BIIB May 15th Options Trading
March 27, 2020
Investors in Biogen Inc (BIIB) saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options chain...
From Market News Video
Swiss drugmaker Novartis on Friday won a key European recommendation for its gene therapy Zolgensma against spinal muscular atrophy (SMA), clearing a hurdle for $2.1 million per patient treatment for...
The coronavirus stock market crash is costing investors. That includes Warren Buffett. But he likely wishes he owned more of three S&P 500 stocks.
Veeva Systems' CRM Product Is Seeing Ten Times More Usage During Coronavirus Pandemic
March 27, 2020
The customer relationship management (CRM) product developed by Veeva Systems (NYSE: VEEV) is seeing ten times more usage during the ...
Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval
March 26, 2020
Coronavirus update: Global case count 487,646, 22,030 deaths, and jobless benefit seekers soar to historic levels
March 26, 2020
The number of global cases of the coronavirus that causes COVID-19 edged closer to half a million on Thursday, and U.S. jobless claims soared to a historic level as workers were laid off or furloughed...
4 Reasons Biotech Stocks Are a Buy Right Now
March 25, 2020
Biotech companies have outperformed the general market -- and there are plenty of reasons to remain optimistic.
Better Buy: AbbVie vs. Biogen
March 24, 2020
Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?
March 23, 2020
Global events, meetings and symposiums are being canceled in droves as a precautionary measure to help contain the coronavirus ...
40 Stocks Moving in Thursday's Pre-Market Session
March 19, 2020
Gainers Chanticleer Holdings, Inc. (NASDAQ: BURG) shares rose 117.1% to $1.52 in pre-market trading after gaining around 35% on ...
Coronavirus delays Biogen's Spinraza for some patients
March 18, 2020
U.S. drugmaker Biogen Inc said on Wednesday that some patients on its drug Spinraza - which treats a rare disorder called spinal muscular atrophy (SMA) - are having their treatments postponed to...
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
March 15, 2020
The biopharma space bled along with the rest of the market andCOVID-19 levered biotechs weren't spared either. Biogen Inc ...
Better Buy: Biogen vs. Amgen
March 15, 2020
Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep These Five Under Observation
March 14, 2020
In the coronavirus bear market, all stocks are under quarantine. But keep health care stocks Vertex, Biogen, Dexcom, Eli Lilly, Masimo under observation.
Why These Drug Stocks Soared Today
March 13, 2020
An overall market rebound and a presidential press conference carried several biotech and pharmaceutical stocks markedly higher.
Eli Lilly Co and privately-held AbCellera Biologics Inc on Thursday announced they would co-develop antibody products for the treatment and prevention of COVID-19, a flu-like disease caused by the...
Drug developer Vir Biotechnology Inc said on Thursday it had signed a letter of intent with Biogen Inc for the development of a potential coronavirus treatment, sending shares up 20%.
Portfolio Highlights: Movers and Shakers - March 2020
March 12, 2020
During the past three months, the S&P 500 Index declined 5% due to fears of a recession brought on by the global impact of the coronavirus. Despite the overall market pullback, the following stocks...
From Blogs - TalkMarkets